Clinical & Laboratory Haematology

β-Thalassemia: the Lebanese experience
pp. 217-227(11)
Authors: INATI, A.; ZEINEH, N.; ISMA'EEL, H.; KOUSSA, S.; GHARZUDDINE, W.; TAHER, A.

A sample distribution programme for erythropoietin
pp. 228-232(5)
Authors: MARSDEN, J. T.; DAY, P.; ELLIS, R.; MARWAH, S.; SAVAGE, G.; SINCLAIR, C.

Hydroxyurea therapy increases plasma erythropoietin in patients with essential thrombocythaemia or polycythaemia vera
pp. 233-236(4)
Authors: JOHANSSON, P.; ANDRÉASSON, B.

Cryoprecipitate production: the use of additives to enhance the yield
pp. 237-240(4)
Authors: YOUSEF, H.; NEURATH, D.; FREEDMAN, M.; ROCK, G.

Quantitation of red cell-bound IgG by an enzyme-linked antiglobulin test in the patients with warm-type autoimmune haemolytic anaemia
pp. 241-244(4)
Authors: FABIJAN´SKA-MITEK, J.; POGŁO´D, R.; ADAMOWICZ-SALACH, A.; ŁOPIEŃSKA, H.

The immature reticulocyte fraction: a negative predictor of the harvesting of CD34 cells for autologous peripheral blood stem cell transplantation
pp. 245-247(3)
Authors: DUNLOP, L. C.; COHEN, J.; HARVEY, M.; GALLO, J.; MOTUM, P.; ROSENFELD, D.

Large variation in t(11;14)(q13;q32) and t(14;18)(q32;q21) translocation product size is confirmed by sequence analysis of PCR products
pp. 248-253(6)
Authors: WICKHAM, C. L.; HARRIES, L. W.; SARSFIELD, P.; JOYNER, M. V.; ELLARD, S.

Expression of the vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukemia: incidence and feasibility of immunohistochemical staining
pp. 254-258(5)
Authors: KHARFAN-DABAJA, M. A.; PATEL, S. A.; OSUNKOYA, A. O.; KOJOURI, K.; KAMBLE, R.; YANG, J.; HASHMI, M.; OZER, H.; SELBY, G. B.

Secondary amyloidosis causing nephrotic syndrome in a patient with non-Hodgkin's lymphoma: quite a rare diagnosis
pp. 259-261(3)
Authors: PAMUK, G. E.; DEMIR, M.; ÖRÜM, H.; TURGUT, B.; ÖZYıLMAZ, F.; TEKGÜNDÜZ, E.

Gene expression changes in a patient presenting nonleukaemic nasal granulocytic sarcoma to acute myelogenous leukaemia using 40 K cDNA microarray
pp. 262-266(5)
Authors: TERAMOTO, H.; MIWA, H.; PATEL, V.; LETWIN, N.; CASTELLONE, M. D.; IMAI, N.; SHIKAMI, M.; IMAMURA, A.; GUTKIND, J. S.; NITTA, M.; LEE, N. H.

Bortezomib in relapsed multiple myeloma complicated by extramedullary plasmacytomas
pp. 267-269(3)
Authors: HUGHES, M.; MICALLEF-EYNAUD, P.

Mild dehydrated hereditary stomatocytosis revealed by marked hepatosiderosis
pp. 270-274(5)
Authors: SYFUSS, P.-Y.; CIUPEA, A.; BRAHIMI, S.; CYNOBER, T.; STEWART, G. W.; GRANDCHAMP, B.; BEAUMONT, C.; TCHERNIA, G.; Delaunay, J.; WAGNER, J.-C.

Oral pharmacologic doses of cobalamin may not be as effective as parenteral cobalamin therapy in reversing hyperhomocystinemia and methylmalonic acidemia in apparently normal subjects
pp. 275-278(4)
Author: SOLOMON, L. R.

Isolated limb infusion with cytotoxic agent for treatment of localized refractory cutaneous T-cell lymphoma
pp. 279-281(3)
Authors: ELHASSADI, E.; EGAN, E.; O'SULLIVAN, G.; MOHAMED, R.

Myelodysplastic syndrome transformed into Acute lymphoblastic leukaemia (FAB:L3)
pp. 282-283(2)
Authors: ZAININA, S.; CHEONG, S. K.

A study to assess patient opinion of safety and efficacy and influences on choice of treatment of haemophilia A
pp. 284-285(2)
Author: Mondorf, W.

Early onset multiple alloimmunization (anti-E and anti-Jk^b) in a thalassaemic
pp. 286-287(2)

Effectiveness of rituximab as prophylaxis in thrombotic thrombocytopenic purpura
pp. 288-289(2)

Corrigendum
pp. 290-290(1)